ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Kinetosis Drugs Market Research Report 2025
Published Date: July 2025
|
Report Code: QYRE-Auto-18J720
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Kinetosis Drugs Market Insights and Forecast to 2028
BUY CHAPTERS

Global Kinetosis Drugs Market Research Report 2025

Code: QYRE-Auto-18J720
Report
July 2025
Pages:84
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
GlaxoSmithKline PLC
Prestige Brands
WellSpring Pharmaceutical Corporation
Baxter International
Sandoz Inc
Pfizer Inc
Myungmoon Pharm
Caleb Pharmaceuticals
Viatris

Kinetosis Drugs Market Size

The global market for Kinetosis Drugs was valued at US$ 417 million in the year 2024 and is projected to reach a revised size of US$ 507 million by 2031, growing at a CAGR of 2.9% during the forecast period.

Kinetosis Drugs Market

Kinetosis Drugs Market

Kinetosis is a common problem in people traveling by car, train, airplanes, and especially boats. Motion sickness is a condition experienced by patient caused due to difference between the visually perceived motion and vestibular system’s senses of movement. Motion sickness is characterized by a set of symptoms such as nausea, fatigue, and dizziness.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Kinetosis Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Kinetosis Drugs.
The Kinetosis Drugs market size, estimations, and forecasts are provided in terms of sales volume (Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Kinetosis Drugs market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Kinetosis Drugs manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Kinetosis Drugs Market Report

Report Metric Details
Report Name Kinetosis Drugs Market
Accounted market size in year US$ 417 million
Forecasted market size in 2031 US$ 507 million
CAGR 2.9%
Base Year year
Forecasted years 2025 - 2031
Segment by Type
  • Anticholinergic
  • Antihistamines
  • Others
Segment by Application
  • Adults
  • Children
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company GlaxoSmithKline, Prestige Brands, WellSpring Pharmaceutical Corporation, Baxter International, Viatris, Sandoz, Pfizer, Myungmoon Pharm, Caleb Pharmaceuticals
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Kinetosis Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Kinetosis Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

How fast is Kinetosis Drugs Market growing?

Ans: The Kinetosis Drugs Market witnessing a CAGR of 2.9% during the forecast period 2025-2031.

What is the Kinetosis Drugs Market size in 2031?

Ans: The Kinetosis Drugs Market size in 2031 will be US$ 507 million.

Who are the main players in the Kinetosis Drugs Market report?

Ans: The main players in the Kinetosis Drugs Market are GlaxoSmithKline, Prestige Brands, WellSpring Pharmaceutical Corporation, Baxter International, Viatris, Sandoz, Pfizer, Myungmoon Pharm, Caleb Pharmaceuticals

What are the Application segmentation covered in the Kinetosis Drugs Market report?

Ans: The Applications covered in the Kinetosis Drugs Market report are Adults, Children

What are the Type segmentation covered in the Kinetosis Drugs Market report?

Ans: The Types covered in the Kinetosis Drugs Market report are Anticholinergic, Antihistamines, Others

1 Kinetosis Drugs Market Overview
1.1 Product Definition
1.2 Kinetosis Drugs by Type
1.2.1 Global Kinetosis Drugs Market Value Comparison by Type (2024 VS 2031)
1.2.2 Anticholinergic
1.2.3 Antihistamines
1.2.4 Others
1.3 Kinetosis Drugs by Application
1.3.1 Global Kinetosis Drugs Market Value by Application (2024 VS 2031)
1.3.2 Adults
1.3.3 Children
1.4 Global Kinetosis Drugs Market Size Estimates and Forecasts
1.4.1 Global Kinetosis Drugs Revenue 2020-2031
1.4.2 Global Kinetosis Drugs Sales 2020-2031
1.4.3 Global Kinetosis Drugs Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Kinetosis Drugs Market Competition by Manufacturers
2.1 Global Kinetosis Drugs Sales Market Share by Manufacturers (2020-2025)
2.2 Global Kinetosis Drugs Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Kinetosis Drugs Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Kinetosis Drugs, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Kinetosis Drugs, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Kinetosis Drugs, Product Type & Application
2.7 Global Key Manufacturers of Kinetosis Drugs, Date of Enter into This Industry
2.8 Global Kinetosis Drugs Market Competitive Situation and Trends
2.8.1 Global Kinetosis Drugs Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Kinetosis Drugs Players Market Share by Revenue
2.8.3 Global Kinetosis Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Kinetosis Drugs Market Scenario by Region
3.1 Global Kinetosis Drugs Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Kinetosis Drugs Sales by Region: 2020-2031
3.2.1 Global Kinetosis Drugs Sales by Region: 2020-2025
3.2.2 Global Kinetosis Drugs Sales by Region: 2026-2031
3.3 Global Kinetosis Drugs Revenue by Region: 2020-2031
3.3.1 Global Kinetosis Drugs Revenue by Region: 2020-2025
3.3.2 Global Kinetosis Drugs Revenue by Region: 2026-2031
3.4 North America Kinetosis Drugs Market Facts & Figures by Country
3.4.1 North America Kinetosis Drugs Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Kinetosis Drugs Sales by Country (2020-2031)
3.4.3 North America Kinetosis Drugs Revenue by Country (2020-2031)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Kinetosis Drugs Market Facts & Figures by Country
3.5.1 Europe Kinetosis Drugs Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Kinetosis Drugs Sales by Country (2020-2031)
3.5.3 Europe Kinetosis Drugs Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Kinetosis Drugs Market Facts & Figures by Region
3.6.1 Asia Pacific Kinetosis Drugs Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Kinetosis Drugs Sales by Region (2020-2031)
3.6.3 Asia Pacific Kinetosis Drugs Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Kinetosis Drugs Market Facts & Figures by Country
3.7.1 Latin America Kinetosis Drugs Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Kinetosis Drugs Sales by Country (2020-2031)
3.7.3 Latin America Kinetosis Drugs Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Kinetosis Drugs Market Facts & Figures by Country
3.8.1 Middle East and Africa Kinetosis Drugs Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Kinetosis Drugs Sales by Country (2020-2031)
3.8.3 Middle East and Africa Kinetosis Drugs Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Kinetosis Drugs Sales by Type (2020-2031)
4.1.1 Global Kinetosis Drugs Sales by Type (2020-2025)
4.1.2 Global Kinetosis Drugs Sales by Type (2026-2031)
4.1.3 Global Kinetosis Drugs Sales Market Share by Type (2020-2031)
4.2 Global Kinetosis Drugs Revenue by Type (2020-2031)
4.2.1 Global Kinetosis Drugs Revenue by Type (2020-2025)
4.2.2 Global Kinetosis Drugs Revenue by Type (2026-2031)
4.2.3 Global Kinetosis Drugs Revenue Market Share by Type (2020-2031)
4.3 Global Kinetosis Drugs Price by Type (2020-2031)
5 Segment by Application
5.1 Global Kinetosis Drugs Sales by Application (2020-2031)
5.1.1 Global Kinetosis Drugs Sales by Application (2020-2025)
5.1.2 Global Kinetosis Drugs Sales by Application (2026-2031)
5.1.3 Global Kinetosis Drugs Sales Market Share by Application (2020-2031)
5.2 Global Kinetosis Drugs Revenue by Application (2020-2031)
5.2.1 Global Kinetosis Drugs Revenue by Application (2020-2025)
5.2.2 Global Kinetosis Drugs Revenue by Application (2026-2031)
5.2.3 Global Kinetosis Drugs Revenue Market Share by Application (2020-2031)
5.3 Global Kinetosis Drugs Price by Application (2020-2031)
6 Key Companies Profiled
6.1 GlaxoSmithKline
6.1.1 GlaxoSmithKline Company Information
6.1.2 GlaxoSmithKline Description and Business Overview
6.1.3 GlaxoSmithKline Kinetosis Drugs Sales, Revenue and Gross Margin (2020-2025)
6.1.4 GlaxoSmithKline Kinetosis Drugs Product Portfolio
6.1.5 GlaxoSmithKline Recent Developments/Updates
6.2 Prestige Brands
6.2.1 Prestige Brands Company Information
6.2.2 Prestige Brands Description and Business Overview
6.2.3 Prestige Brands Kinetosis Drugs Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Prestige Brands Kinetosis Drugs Product Portfolio
6.2.5 Prestige Brands Recent Developments/Updates
6.3 WellSpring Pharmaceutical Corporation
6.3.1 WellSpring Pharmaceutical Corporation Company Information
6.3.2 WellSpring Pharmaceutical Corporation Description and Business Overview
6.3.3 WellSpring Pharmaceutical Corporation Kinetosis Drugs Sales, Revenue and Gross Margin (2020-2025)
6.3.4 WellSpring Pharmaceutical Corporation Kinetosis Drugs Product Portfolio
6.3.5 WellSpring Pharmaceutical Corporation Recent Developments/Updates
6.4 Baxter International
6.4.1 Baxter International Company Information
6.4.2 Baxter International Description and Business Overview
6.4.3 Baxter International Kinetosis Drugs Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Baxter International Kinetosis Drugs Product Portfolio
6.4.5 Baxter International Recent Developments/Updates
6.5 Viatris
6.5.1 Viatris Company Information
6.5.2 Viatris Description and Business Overview
6.5.3 Viatris Kinetosis Drugs Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Viatris Kinetosis Drugs Product Portfolio
6.5.5 Viatris Recent Developments/Updates
6.6 Sandoz
6.6.1 Sandoz Company Information
6.6.2 Sandoz Description and Business Overview
6.6.3 Sandoz Kinetosis Drugs Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Sandoz Kinetosis Drugs Product Portfolio
6.6.5 Sandoz Recent Developments/Updates
6.7 Pfizer
6.7.1 Pfizer Company Information
6.7.2 Pfizer Description and Business Overview
6.7.3 Pfizer Kinetosis Drugs Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Pfizer Kinetosis Drugs Product Portfolio
6.7.5 Pfizer Recent Developments/Updates
6.8 Myungmoon Pharm
6.8.1 Myungmoon Pharm Company Information
6.8.2 Myungmoon Pharm Description and Business Overview
6.8.3 Myungmoon Pharm Kinetosis Drugs Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Myungmoon Pharm Kinetosis Drugs Product Portfolio
6.8.5 Myungmoon Pharm Recent Developments/Updates
6.9 Caleb Pharmaceuticals
6.9.1 Caleb Pharmaceuticals Company Information
6.9.2 Caleb Pharmaceuticals Description and Business Overview
6.9.3 Caleb Pharmaceuticals Kinetosis Drugs Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Caleb Pharmaceuticals Kinetosis Drugs Product Portfolio
6.9.5 Caleb Pharmaceuticals Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Kinetosis Drugs Industry Chain Analysis
7.2 Kinetosis Drugs Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Kinetosis Drugs Production Mode & Process Analysis
7.4 Kinetosis Drugs Sales and Marketing
7.4.1 Kinetosis Drugs Sales Channels
7.4.2 Kinetosis Drugs Distributors
7.5 Kinetosis Drugs Customer Analysis
8 Kinetosis Drugs Market Dynamics
8.1 Kinetosis Drugs Industry Trends
8.2 Kinetosis Drugs Market Drivers
8.3 Kinetosis Drugs Market Challenges
8.4 Kinetosis Drugs Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
FEATURED COMPANIES
GlaxoSmithKline PLC
Prestige Brands
WellSpring Pharmaceutical Corporation
Baxter International
Sandoz Inc
Pfizer Inc
Myungmoon Pharm
Caleb Pharmaceuticals
Viatris
List of Tables
 Table 1. Global Kinetosis Drugs Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Kinetosis Drugs Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Kinetosis Drugs Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Kinetosis Drugs Sales (Units) of Key Manufacturers (2020-2025)
 Table 5. Global Kinetosis Drugs Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Kinetosis Drugs Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Kinetosis Drugs Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Kinetosis Drugs Average Price (USD/Unit) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Kinetosis Drugs, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Kinetosis Drugs, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Kinetosis Drugs, Product Type & Application
 Table 12. Global Key Manufacturers of Kinetosis Drugs, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Kinetosis Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Kinetosis Drugs as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Kinetosis Drugs Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Kinetosis Drugs Sales by Region (2020-2025) & (Units)
 Table 18. Global Kinetosis Drugs Sales Market Share by Region (2020-2025)
 Table 19. Global Kinetosis Drugs Sales by Region (2026-2031) & (Units)
 Table 20. Global Kinetosis Drugs Sales Market Share by Region (2026-2031)
 Table 21. Global Kinetosis Drugs Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Kinetosis Drugs Revenue Market Share by Region (2020-2025)
 Table 23. Global Kinetosis Drugs Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Kinetosis Drugs Revenue Market Share by Region (2026-2031)
 Table 25. North America Kinetosis Drugs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Kinetosis Drugs Sales by Country (2020-2025) & (Units)
 Table 27. North America Kinetosis Drugs Sales by Country (2026-2031) & (Units)
 Table 28. North America Kinetosis Drugs Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Kinetosis Drugs Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Kinetosis Drugs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Kinetosis Drugs Sales by Country (2020-2025) & (Units)
 Table 32. Europe Kinetosis Drugs Sales by Country (2026-2031) & (Units)
 Table 33. Europe Kinetosis Drugs Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Kinetosis Drugs Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Kinetosis Drugs Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Kinetosis Drugs Sales by Region (2020-2025) & (Units)
 Table 37. Asia Pacific Kinetosis Drugs Sales by Region (2026-2031) & (Units)
 Table 38. Asia Pacific Kinetosis Drugs Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Kinetosis Drugs Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Kinetosis Drugs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Kinetosis Drugs Sales by Country (2020-2025) & (Units)
 Table 42. Latin America Kinetosis Drugs Sales by Country (2026-2031) & (Units)
 Table 43. Latin America Kinetosis Drugs Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Kinetosis Drugs Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Kinetosis Drugs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Kinetosis Drugs Sales by Country (2020-2025) & (Units)
 Table 47. Middle East and Africa Kinetosis Drugs Sales by Country (2026-2031) & (Units)
 Table 48. Middle East and Africa Kinetosis Drugs Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Kinetosis Drugs Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Kinetosis Drugs Sales (Units) by Type (2020-2025)
 Table 51. Global Kinetosis Drugs Sales (Units) by Type (2026-2031)
 Table 52. Global Kinetosis Drugs Sales Market Share by Type (2020-2025)
 Table 53. Global Kinetosis Drugs Sales Market Share by Type (2026-2031)
 Table 54. Global Kinetosis Drugs Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Kinetosis Drugs Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Kinetosis Drugs Revenue Market Share by Type (2020-2025)
 Table 57. Global Kinetosis Drugs Revenue Market Share by Type (2026-2031)
 Table 58. Global Kinetosis Drugs Price (USD/Unit) by Type (2020-2025)
 Table 59. Global Kinetosis Drugs Price (USD/Unit) by Type (2026-2031)
 Table 60. Global Kinetosis Drugs Sales (Units) by Application (2020-2025)
 Table 61. Global Kinetosis Drugs Sales (Units) by Application (2026-2031)
 Table 62. Global Kinetosis Drugs Sales Market Share by Application (2020-2025)
 Table 63. Global Kinetosis Drugs Sales Market Share by Application (2026-2031)
 Table 64. Global Kinetosis Drugs Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Kinetosis Drugs Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Kinetosis Drugs Revenue Market Share by Application (2020-2025)
 Table 67. Global Kinetosis Drugs Revenue Market Share by Application (2026-2031)
 Table 68. Global Kinetosis Drugs Price (USD/Unit) by Application (2020-2025)
 Table 69. Global Kinetosis Drugs Price (USD/Unit) by Application (2026-2031)
 Table 70. GlaxoSmithKline Company Information
 Table 71. GlaxoSmithKline Description and Business Overview
 Table 72. GlaxoSmithKline Kinetosis Drugs Sales (Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 73. GlaxoSmithKline Kinetosis Drugs Product
 Table 74. GlaxoSmithKline Recent Developments/Updates
 Table 75. Prestige Brands Company Information
 Table 76. Prestige Brands Description and Business Overview
 Table 77. Prestige Brands Kinetosis Drugs Sales (Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 78. Prestige Brands Kinetosis Drugs Product
 Table 79. Prestige Brands Recent Developments/Updates
 Table 80. WellSpring Pharmaceutical Corporation Company Information
 Table 81. WellSpring Pharmaceutical Corporation Description and Business Overview
 Table 82. WellSpring Pharmaceutical Corporation Kinetosis Drugs Sales (Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 83. WellSpring Pharmaceutical Corporation Kinetosis Drugs Product
 Table 84. WellSpring Pharmaceutical Corporation Recent Developments/Updates
 Table 85. Baxter International Company Information
 Table 86. Baxter International Description and Business Overview
 Table 87. Baxter International Kinetosis Drugs Sales (Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 88. Baxter International Kinetosis Drugs Product
 Table 89. Baxter International Recent Developments/Updates
 Table 90. Viatris Company Information
 Table 91. Viatris Description and Business Overview
 Table 92. Viatris Kinetosis Drugs Sales (Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 93. Viatris Kinetosis Drugs Product
 Table 94. Viatris Recent Developments/Updates
 Table 95. Sandoz Company Information
 Table 96. Sandoz Description and Business Overview
 Table 97. Sandoz Kinetosis Drugs Sales (Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 98. Sandoz Kinetosis Drugs Product
 Table 99. Sandoz Recent Developments/Updates
 Table 100. Pfizer Company Information
 Table 101. Pfizer Description and Business Overview
 Table 102. Pfizer Kinetosis Drugs Sales (Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 103. Pfizer Kinetosis Drugs Product
 Table 104. Pfizer Recent Developments/Updates
 Table 105. Myungmoon Pharm Company Information
 Table 106. Myungmoon Pharm Description and Business Overview
 Table 107. Myungmoon Pharm Kinetosis Drugs Sales (Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 108. Myungmoon Pharm Kinetosis Drugs Product
 Table 109. Myungmoon Pharm Recent Developments/Updates
 Table 110. Caleb Pharmaceuticals Company Information
 Table 111. Caleb Pharmaceuticals Description and Business Overview
 Table 112. Caleb Pharmaceuticals Kinetosis Drugs Sales (Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 113. Caleb Pharmaceuticals Kinetosis Drugs Product
 Table 114. Caleb Pharmaceuticals Recent Developments/Updates
 Table 115. Key Raw Materials Lists
 Table 116. Raw Materials Key Suppliers Lists
 Table 117. Kinetosis Drugs Distributors List
 Table 118. Kinetosis Drugs Customers List
 Table 119. Kinetosis Drugs Market Trends
 Table 120. Kinetosis Drugs Market Drivers
 Table 121. Kinetosis Drugs Market Challenges
 Table 122. Kinetosis Drugs Market Restraints
 Table 123. Research Programs/Design for This Report
 Table 124. Key Data Information from Secondary Sources
 Table 125. Key Data Information from Primary Sources
 Table 126. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Kinetosis Drugs
 Figure 2. Global Kinetosis Drugs Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Kinetosis Drugs Market Share by Type: 2024 & 2031
 Figure 4. Anticholinergic Product Picture
 Figure 5. Antihistamines Product Picture
 Figure 6. Others Product Picture
 Figure 7. Global Kinetosis Drugs Market Value by Application (2020-2031) & (US$ Million)
 Figure 8. Global Kinetosis Drugs Market Share by Application: 2024 & 2031
 Figure 9. Adults
 Figure 10. Children
 Figure 11. Global Kinetosis Drugs Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 12. Global Kinetosis Drugs Market Size (2020-2031) & (US$ Million)
 Figure 13. Global Kinetosis Drugs Sales (2020-2031) & (Units)
 Figure 14. Global Kinetosis Drugs Average Price (USD/Unit) & (2020-2031)
 Figure 15. Kinetosis Drugs Report Years Considered
 Figure 16. Kinetosis Drugs Sales Share by Manufacturers in 2024
 Figure 17. Global Kinetosis Drugs Revenue Share by Manufacturers in 2024
 Figure 18. Global 5 and 10 Largest Kinetosis Drugs Players: Market Share by Revenue in Kinetosis Drugs in 2024
 Figure 19. Kinetosis Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 20. Global Kinetosis Drugs Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 21. North America Kinetosis Drugs Sales Market Share by Country (2020-2031)
 Figure 22. North America Kinetosis Drugs Revenue Market Share by Country (2020-2031)
 Figure 23. U.S. Kinetosis Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 24. Canada Kinetosis Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 25. Europe Kinetosis Drugs Sales Market Share by Country (2020-2031)
 Figure 26. Europe Kinetosis Drugs Revenue Market Share by Country (2020-2031)
 Figure 27. Germany Kinetosis Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 28. France Kinetosis Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 29. U.K. Kinetosis Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 30. Italy Kinetosis Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 31. Russia Kinetosis Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 32. Asia Pacific Kinetosis Drugs Sales Market Share by Region (2020-2031)
 Figure 33. Asia Pacific Kinetosis Drugs Revenue Market Share by Region (2020-2031)
 Figure 34. China Kinetosis Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 35. Japan Kinetosis Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 36. South Korea Kinetosis Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 37. India Kinetosis Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. Australia Kinetosis Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. Taiwan Kinetosis Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. Indonesia Kinetosis Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. Thailand Kinetosis Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 42. Malaysia Kinetosis Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 43. Philippines Kinetosis Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 44. Latin America Kinetosis Drugs Sales Market Share by Country (2020-2031)
 Figure 45. Latin America Kinetosis Drugs Revenue Market Share by Country (2020-2031)
 Figure 46. Mexico Kinetosis Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 47. Brazil Kinetosis Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 48. Argentina Kinetosis Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 49. Middle East and Africa Kinetosis Drugs Sales Market Share by Country (2020-2031)
 Figure 50. Middle East and Africa Kinetosis Drugs Revenue Market Share by Country (2020-2031)
 Figure 51. Turkey Kinetosis Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 52. Saudi Arabia Kinetosis Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 53. U.A.E Kinetosis Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 54. Global Sales Market Share of Kinetosis Drugs by Type (2020-2031)
 Figure 55. Global Revenue Market Share of Kinetosis Drugs by Type (2020-2031)
 Figure 56. Global Kinetosis Drugs Price (USD/Unit) by Type (2020-2031)
 Figure 57. Global Sales Market Share of Kinetosis Drugs by Application (2020-2031)
 Figure 58. Global Revenue Market Share of Kinetosis Drugs by Application (2020-2031)
 Figure 59. Global Kinetosis Drugs Price (USD/Unit) by Application (2020-2031)
 Figure 60. Kinetosis Drugs Value Chain
 Figure 61. Channels of Distribution (Direct Vs Distribution)
 Figure 62. Bottom-up and Top-down Approaches for This Report
 Figure 63. Data Triangulation
 Figure 64. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Seventh Sense AI

SIMILAR REPORTS

Global Seasickness Medicine Market Insights Forecast to 2030
Global Travel Sickness Drugs Market Insights Forecast to 2030
Global Airsickness Treatment Market Insights Forecast to 2030
Global Antihistamines Travel Sickness Drugs Market Insights Forecast to 2030
Global Anticholinergic Travel Sickness Drugs Market Insights Forecast to 2030
Motion Sickness Pills Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Motion Sickness Durg Market Insights Forecast to 2030
Motion Sickness Medicine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Amebiasis Drugs Market Insights Forecast to 2030
Global Amebiasis Treatment Market Insights Forecast to 2030
Global Amebiasis Market Insights Forecast to 2030
Global Amebiasis Therapeutics Market Insights Forecast to 2030
Global Jet Lag Treatment Market Insights Forecast to 2030
Global Air Sickness Bags Market Insights Forecast to 2030
Global Dystonia Drugs Market Research Report 2025
Global Sleep Movement Disorder Drug Market Insights Forecast to 2030
Global Wearable Anti motion Sickness Bracelet Market Research Report 2024
Jet Lag Medication Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Motion Sickness Patch Market
Global Head Lice Drug Market Insights Forecast to 2030
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions